Patents by Inventor Shen-Nien Wang

Shen-Nien Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11800857
    Abstract: A liver lesion-mouse model which is a liver-specific ISX gene expression and p53 gene knockout transgenic mouse, wherein liver lesion develops after the mouse is fed with a high calorie diet.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: October 31, 2023
    Assignee: Kaohsiung Medical University
    Inventors: Shih-Hsien Hsu, Li-Ting Wang, Shen-Nien Wang, Kwei-Yan Liu
  • Publication number: 20210100226
    Abstract: A liver lesion-mouse model which is a liver-specific ISX gene expression and p53 gene knockout transgenic mouse, wherein liver lesion develops after the mouse is fed with a high calorie diet.
    Type: Application
    Filed: October 2, 2019
    Publication date: April 8, 2021
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Shih-Hsien Hsu, Li-Ting Wang, Shen-Nien Wang, Kwei-Yan Liu
  • Publication number: 20110098219
    Abstract: The present invention cures hepatic cancer by MPA with the help of leptin. A therapeutic drug of MPA combined with leptin is applied to a liver cancer patient. Or, MPA can be directly applied to a patient having a high leptin expression. Or, if a patient has a low leptin expression, MPA is applied to the patient after leptin expression is increased. Hence, expression of leptin can be taken as a predictive factor and a prognostic factor of treatment effect on curing the patient with MPA.
    Type: Application
    Filed: January 19, 2010
    Publication date: April 28, 2011
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Shen-Nien Wang, Yao-Tsung Yeh, King-Teh Lee, Hsiang-Jen Yang, Sheau-Fang Yang